Post-immunotherapy imaging in lung cancer

Volume: 77, Issue: 1, Pages: 44 - 57
Published: Jan 1, 2022
Abstract
By boosting the immune system, immunotherapy with immune checkpoint inhibitors (ICIs) has altered the management of patients with various cancers including those with metastatic non-small cell lung cancer (NSCLC). As a result of immune system activation, ICIs are associated with unique response patterns (that are not addressed by traditional response criteria) and inflammatory side effects termed immune-related adverse events. In this article,...
Paper Details
Title
Post-immunotherapy imaging in lung cancer
Published Date
Jan 1, 2022
Volume
77
Issue
1
Pages
44 - 57
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.